JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BUNNEY, B. S.
Right arrow Articles by AGHAJANIAN, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BUNNEY, B. S.
Right arrow Articles by AGHAJANIAN, G. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 185, Issue 3, 560-571, 1973
Copyright © 1973 by American Society for Pharmacology and Experimental Therapeutics


DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY

BENJAMIN S. BUNNEY 1, JUDITH R. WALTERS 1, ROBERT H. ROTH 1, and GEORGE K. AGHAJANIAN 1

1 Departments of Psychiatry and Pharmacology, Yale University School of Medicine; Connecticut Mental Health center, New Haven, Connecticut

The effects of amphetamine, various phenothiazines and haloperidol on dopaminergic neurons in the substantia nigra and ventral tegmental area of the rat midbrain were studied in anesthetized and gallamine-paralyzed animals using a single unit recording technique. d-Amphetamine administered intravenously markedly decreased the spontaneous activity of dopaminergic neurons in the substantia nigra and ventral tegmental area. Antipsychotic phenothiazines and haloperidol increased the firing rate of these cells and reversed the d-amphetamine depression. Promethazin. a phenothiazine lacking antipsychotic efficacy, had no effect. In an experiment designed to correlate changes in firing rate with dopamine metabolism, neostriatal 3,4-dihydroxyphenylacetic acid concentrations were determined before and after administration of chlorpromazine (1.25 mg/kg), amphetamine (1.25 mg/kg) and promethazine (10 mg/kg). Neostriatal 3,4-dihydroxyphenylacetic acid was inceased by chlorpromazine,decreaed by amphetamine and unchanged by promethazine, thus paralleling the effects of these drugs on dopaminergic unit activity. These findings, together with our single unit recording results, are compatible with the neuronal feedback hypothesis orignally suggested as a mechanism by which these drugs might alter dopamine metabolism.

Accepted on February 26, 1973




This article has been cited by other articles:


Home page
J. Neurosci.Home page
H. Ji and P. D. Shepard
Lateral Habenula Stimulation Inhibits Rat Midbrain Dopamine Neurons through a GABAA Receptor-Mediated Mechanism
J. Neurosci., June 27, 2007; 27(26): 6923 - 6930.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Gao, C.-L. Liu, S. Yang, G.-Z. Jin, B. S. Bunney, and W.-X. Shi
Functional Coupling between the Prefrontal Cortex and Dopamine Neurons in the Ventral Tegmental Area
J. Neurosci., May 16, 2007; 27(20): 5414 - 5421.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Yanovsky, S. Velte, and U. Misgeld
Ca2+ release-dependent hyperpolarizations modulate the firing pattern of juvenile GABA neurons in mouse substantia nigra pars reticulata in vitro
J. Physiol., December 15, 2006; 577(3): 879 - 890.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. H. Hansen, C. Ebbesen, C. Mathiesen, P. Weikop, L. C. Ronn, O. Waroux, J. Scuvee-Moreau, V. Seutin, and J. D. Mikkelsen
The KCNQ Channel Opener Retigabine Inhibits the Activity of Mesencephalic Dopaminergic Systems of the Rat
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1006 - 1019.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Zhou, B. S. Bunney, and W.-X. Shi
Differential Effects of Cocaine on Firing Rate and Pattern of Dopamine Neurons: Role of {alpha}1 Receptors and Comparison with L-Dopa and Apomorphine
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 196 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Rasmussen, M. J. Benvenga, F. P. Bymaster, D. O. Calligaro, I. R. Cohen, J. F. Falcone, S. K. Hemrick-Luecke, F. M. Martin, N. A. Moore, L. K. Nisenbaum, et al.
Preclinical Pharmacology of FMPD [6-Fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: A Potential Novel Antipsychotic with Lower Histamine H1 Receptor Affinity Than Olanzapine
J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1265 - 1277.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
W.-X. Shi
Slow Oscillatory Firing: A Major Firing Pattern of Dopamine Neurons in the Ventral Tegmental Area
J Neurophysiol, November 1, 2005; 94(5): 3516 - 3522.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Narendran, D.-R. Hwang, M. Slifstein, Y. Hwang, Y. Huang, J. Ekelund, O. Guillin, E. Scher, D. Martinez, and M. Laruelle
Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C]N-Propyl-norapomorphine and [11C]Raclopride in Baboons
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 80 - 90.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. B. McCall, K. J. Lookingland, P. J. Bedard, and R. M. Huff
Sumanirole, a Highly Dopamine D2-Selective Receptor Agonist: In Vitro and in Vivo Pharmacological Characterization and Efficacy in Animal Models of Parkinson's Disease
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1248 - 1256.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Degos, J.-M. Deniau, A.-M. Thierry, J. Glowinski, L. Pezard, and N. Maurice
Neuroleptic-Induced Catalepsy: Electrophysiological Mechanisms of Functional Recovery Induced by High-Frequency Stimulation of the Subthalamic Nucleus
J. Neurosci., August 17, 2005; 25(33): 7687 - 7696.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Ishida, M. Murata, N. Katagiri, M. Ishikawa, K. Abe, M. Kato, I. Utsunomiya, and K. Taguchi
Effects of {beta}-Phenylethylamine on Dopaminergic Neurons of the Ventral Tegmental Area in the Rat: A Combined Electrophysiological and Microdialysis Study
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 916 - 922.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. G. Olson, C. P. Zabetian, C. A. Bolanos, S. Edwards, M. Barrot, A. J. Eisch, T. Hughes, D. W. Self, R. L. Neve, and E. J. Nestler
Regulation of Drug Reward by cAMP Response Element-Binding Protein: Evidence for Two Functionally Distinct Subregions of the Ventral Tegmental Area
J. Neurosci., June 8, 2005; 25(23): 5553 - 5562.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Robinson, D. M. Smith, S. J. Y. Mizumori, and R. D. Palmiter
From The Cover: Firing properties of dopamine neurons in freely moving dopamine-deficient mice: Effects of dopamine receptor activation and anesthesia
PNAS, September 7, 2004; 101(36): 13329 - 13334.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Pierucci, V. Di Matteo, and E. Esposito
Stimulation of Serotonin2C Receptors Blocks the Hyperactivation of Midbrain Dopamine Neurons Induced by Nicotine Administration
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 109 - 118.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
N. Maurice, A.-M. Thierry, J. Glowinski, and J.-M. Deniau
Spontaneous and Evoked Activity of Substantia Nigra Pars Reticulata Neurons during High-Frequency Stimulation of the Subthalamic Nucleus
J. Neurosci., October 29, 2003; 23(30): 9929 - 9936.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Q. V. Hoang, D. Bajic, M. Yanagisawa, S. Nakajima, and Y. Nakajima
Effects of Orexin (Hypocretin) on GIRK Channels
J Neurophysiol, August 1, 2003; 90(2): 693 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Mailly, S. Charpier, A. Menetrey, and J.-M. Deniau
Three-Dimensional Organization of the Recurrent Axon Collateral Network of the Substantia Nigra Pars Reticulata Neurons in the Rat
J. Neurosci., June 15, 2003; 23(12): 5247 - 5257.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Bajic, M. Koike, A. M. Albsoul-Younes, S. Nakajima, and Y. Nakajima
Two different inward rectifier K+ channels are effectors for transmitter-induced slow excitation in brain neurons
PNAS, October 29, 2002; 99(22): 14494 - 14499.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Schmitz, C. Schmauss, and D. Sulzer
Altered Dopamine Release and Uptake Kinetics in Mice Lacking D2 Receptors
J. Neurosci., September 15, 2002; 22(18): 8002 - 8009.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. J. Cragg, C. J. Hille, and S. A. Greenfield
Functional Domains in Dorsal Striatum of the Nonhuman Primate Are Defined by the Dynamic Behavior of Dopamine
J. Neurosci., July 1, 2002; 22(13): 5705 - 5712.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. C. RIEGEL and E. D. FRENCH
Abused Inhalants and Central Reward Pathways: Electrophysiological and Behavioral Studies in the Rat
Ann. N.Y. Acad. Sci., June 1, 2002; 965(1): 281 - 291.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Kilts, H. S. Connery, E. G. Arrington, M. M. Lewis, C. P. Lawler, G. S. Oxford, K. L. O'Malley, R. D. Todd, B. L. Blake, D. E. Nichols, et al.
Functional Selectivity of Dopamine Receptor Agonists. II. Actions of Dihydrexidine in D2L Receptor-Transfected MN9D Cells and Pituitary Lactotrophs
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1179 - 1189.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R. S. Scroggs, C. G. Cardenas, J. A. Whittaker, and S. T. Kitai
Muscarine Reduces Calcium-Dependent Electrical Activity in Substantia Nigra Dopaminergic Neurons
J Neurophysiol, December 1, 2001; 86(6): 2966 - 2972.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Mailly, S. Charpier, S. Mahon, A. Menetrey, A. M. Thierry, J. Glowinski, and J. M. Deniau
Dendritic Arborizations of the Rat Substantia Nigra Pars Reticulata Neurons: Spatial Organization and Relation to the Lamellar Compartmentation of Striato-Nigral Projections
J. Neurosci., September 1, 2001; 21(17): 6874 - 6888.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. B. Bunney, S. B. Appel, and M. S. Brodie
Electrophysiological Effects of Cocaethylene, Cocaine, and Ethanol on Dopaminergic Neurons of the Ventral Tegmental Area
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 696 - 703.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
R.-S. Lee, S. C. Steffensen, and S. J. Henriksen
Discharge Profiles of Ventral Tegmental Area GABA Neurons during Movement, Anesthesia, and the Sleep-Wake Cycle
J. Neurosci., March 1, 2001; 21(5): 1757 - 1766.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Marinelli and F. J. White
Enhanced Vulnerability to Cocaine Self-Administration Is Associated with Elevated Impulse Activity of Midbrain Dopamine Neurons
J. Neurosci., December 1, 2000; 20(23): 8876 - 8885.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Wang, R. Xu, T. Sasaoka, S. Tonegawa, M.-P. Kung, and E.-B. Sankoorikal
Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions
J. Neurosci., November 15, 2000; 20(22): 8305 - 8314.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. J. Cragg, C. J. Hille, and S. A. Greenfield
Dopamine Release and Uptake Dynamics within Nonhuman Primate Striatum In Vitro
J. Neurosci., November 1, 2000; 20(21): 8209 - 8217.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. B. Bunney, S. B. Appel, and M. S. Brodie
Cocaine Potentiates Ethanol-Induced Excitation of Dopaminergic Reward Neurons in the Ventral Tegmental Area
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 383 - 389.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
W.-X. Shi, C.-L. Pun, X.-X. Zhang, M. D. Jones, and B. S. Bunney
Dual Effects of D-Amphetamine on Dopamine Neurons Mediated by Dopamine and Nondopamine Receptors
J. Neurosci., May 1, 2000; 20(9): 3504 - 3511.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Y. Iribe, K. Moore, K. C. H. Pang, and J. M. Tepper
Subthalamic Stimulation-Induced Synaptic Responses in Substantia Nigra Pars Compacta Dopaminergic Neurons In Vitro
J Neurophysiol, August 1, 1999; 82(2): 925 - 933.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Maurice, J.-M. Deniau, J. Glowinski, and A.-M. Thierry
Relationships between the Prefrontal Cortex and the Basal Ganglia in the Rat: Physiology of the Cortico-Nigral Circuits
J. Neurosci., June 1, 1999; 19(11): 4674 - 4681.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. X. Ping and P. D. Shepard
Blockade of SK-Type Ca2+-Activated K+ Channels Uncovers a Ca2+-Dependent Slow Afterdepolarization in Nigral Dopamine Neurons
J Neurophysiol, March 1, 1999; 81(3): 977 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Di Giovanni, M. Di Mascio, V. Di Matteo, and E. Esposito
Effects of Acute and Repeated Administration of Amisulpride, a Dopamine D2/D3 Receptor Antagonist, on the Electrical Activity of Midbrain Dopaminergic Neurons
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 51 - 57.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. N. Ruskin, S. S. Rawji, and J. R. Walters
Effects of Full D1 Dopamine Receptor Agonists on Firing Rates in the Globus Pallidus and Substantia Nigra Pars Compacta In Vivo: Tests for D1 Receptor Selectivity and Comparisons to the Partial Agonist SKF 38393
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 272 - 281.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
T. E. Koeltzow, M. Xu, D. C. Cooper, X.-T. Hu, S. Tonegawa, M. E. Wolf, and F. J. White
Alterations in Dopamine Release But Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice
J. Neurosci., March 15, 1998; 18(6): 2231 - 2238.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W.-X. Shi, P. L. Smith, C.-L. Pun, B. Millet, and B. S. Bunney
D1-D2 Interaction in Feedback Control of Midbrain Dopamine Neurons
J. Neurosci., October 15, 1997; 17(20): 7988 - 7994.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. M. Tepper, B.-C. Sun, L. P. Martin, and I. Creese
Functional Roles of Dopamine D2 and D3 Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense Knockdown In Vivo
J. Neurosci., April 1, 1997; 17(7): 2519 - 2530.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. C. Sanudo-Pena and J. M. Walker
Role of the Subthalamic Nucleus in Cannabinoid Actions in the Substantia Nigra of the Rat
J Neurophysiol, March 1, 1997; 77(3): 1635 - 1638.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Walters JR, D. Bergstrom, J. Carlson, T. Chase, and A. Braun
D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects
Science, May 8, 1987; 236(4802): 719 - 722.
[Abstract] [PDF]


Home page
ScienceHome page
D Pickar, R Labarca, M Linnoila, A Roy, D Hommer, D Everett, and S. Paul
Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients
Science, August 31, 1984; 225(4665): 954 - 957.
[Abstract] [PDF]


Home page
ScienceHome page
F. White and R. Wang
Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons
Science, September 9, 1983; 221(4615): 1054 - 1057.
[Abstract] [PDF]


Home page
ScienceHome page
B. Waszcak and Walters JR
Dopamine modulation of the effects of gamma-aminobutyric acid on substantia nigra pars reticulata neurons
Science, April 8, 1983; 220(4593): 218 - 221.
[Abstract] [PDF]


Home page
ScienceHome page
A. A. GRACE and B. S. BUNNEY
Limitations in Identifying Neurotransmitters Within Neurons by Fluorescent Histochemistry Techniques
Science, December 4, 1981; 214(4525): 1152 - 1152.
[PDF]


Home page
ScienceHome page
L. Chiodo and S. Antelman
Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment
Science, November 14, 1980; 210(4471): 799 - 801.
[Abstract] [PDF]


Home page
ScienceHome page
L. Skirboll, A. Grace, and B. Bunney
Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists
Science, October 5, 1979; 206(4414): 80 - 82.
[Abstract] [PDF]


Home page
ScienceHome page
S. Mason, P. Sanberg, and H. Fibiger
Kainic acid lesions of the striatum dissociate amphetamine and apomorphine stereotypy: similarities to Huntingdon's chorea
Science, July 28, 1978; 201(4353): 352 - 355.
[Abstract] [PDF]


Home page
ScienceHome page
J. Barchas, H Akil, G. Elliott, R. Holman, and S. Watson
Behavioral neurochemistry: neuroregulators and behavioral states
Science, May 26, 1978; 200(4344): 964 - 973.
[Abstract] [PDF]


Home page
ScienceHome page
P Lerner, P Nose, E. Gordon, and W Lovenberg
Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover
Science, July 8, 1977; 197(4299): 181 - 183.
[Abstract] [PDF]


Home page
ScienceHome page
B. Bunney and G. Achajanian
d-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway
Science, April 23, 1976; 192(4237): 391 - 393.
[Abstract] [PDF]


Home page
ScienceHome page
P. Groves, C. Wilson, S. Young, and G. Rebec
Self-inhibition by dopaminergic neurons
Science, November 7, 1975; 190(4214): 522 - 528.
[PDF]


Home page
ScienceHome page
P Seeman and T Lee
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons
Science, June 20, 1975; 188(4194): 1217 - 1219.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1973 by the American Society for Pharmacology and Experimental Therapeutics.